Compare Oriental Aromat. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -15.52% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 5.75% signifying low profitability per unit of shareholders funds
The company has declared Negative results for the last 4 consecutive quarters
Despite the size of the company, domestic mutual funds hold only 0% of the company
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 1,037 Cr (Micro Cap)
1,342.00
39
0.15%
0.60
1.48%
1.64
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Aug-08-2025
Risk Adjusted Returns v/s 
Returns Beta
News
Are Oriental Aromatics Ltd latest results good or bad?
Oriental Aromatics Ltd's latest financial results indicate a complex situation characterized by significant operational challenges. In the quarter ending December 2025, the company reported a net profit of negative ₹1.92 crores, marking a substantial decline of 126.89% year-on-year. This represents the first quarterly loss in years, raising concerns about the sustainability of its business model amid a challenging operating environment. Despite this downturn in profitability, the company achieved a net sales growth of 13.03% year-on-year, reaching ₹251.56 crores. However, this growth is juxtaposed against a sequential decline of 7.29% from the previous quarter, suggesting potential difficulties in maintaining revenue momentum. The operating profit before depreciation, interest, and tax (PBDIT) fell to ₹13.22 crores, indicating a significant margin compression of 487 basis points to 5.26%, the lowest record...
Read full news article
Oriental Aromatics Q3 FY26: Profitability Crisis Deepens as Margins Collapse
Oriental Aromatics Limited has reported a deeply concerning Q3 FY26 performance, posting its first quarterly loss in over two years with a net loss of ₹1.92 crores compared to a profit of ₹7.14 crores in Q3 FY25—a staggering 126.89% year-on-year decline. The micro-cap specialty chemicals manufacturer, with a market capitalisation of ₹1,086 crores, witnessed its operating margins compress to just 5.26%, down from 10.13% in the year-ago quarter, signalling severe profitability pressures despite revenue growth of 13.03% to ₹251.56 crores.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Feb-2026 | Source : BSEIntimation of conference call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 to discuss the Financial Performance of the Company for the quarter and nine months ended 31st December 2025.
Board Meeting Intimation for Consideration Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2025
05-Feb-2026 | Source : BSEOriental Aromatics Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2025;
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Jan-2026 | Source : BSERe-submission of Certificate under Regulation 74(5) of SEBI (Depositories & Participant) Regulation 2018 for the quarter ended 31st December 2025.
Corporate Actions 
No Upcoming Board Meetings
Oriental Aromatics Ltd has declared 10% dividend, ex-date: 08 Aug 25
Oriental Aromatics Ltd has announced 5:10 stock split, ex-date: 13 Dec 18
Oriental Aromatics Ltd has announced 1:1 bonus issue, ex-date: 13 Dec 18
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 10 FIIs (0.03%)
Shyamal Anil Bodani (37.08%)
None
19.19%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 13.03% vs 12.75% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -126.89% vs 173.56% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 9.79% vs 7.10% in Sep 2024
Growth in half year ended Sep 2025 is -95.19% vs 811.60% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 10.86% vs 8.90% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -102.07% vs 3,357.43% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 10.98% vs -1.49% in Mar 2024
YoY Growth in year ended Mar 2025 is 277.25% vs -53.90% in Mar 2024






